House of Lords provides guidance on the law of obviousness in patent actions; increased opportunities to obtain supplementary protection certificates for combinations of active ingredients; patent for DNA and protein sequence invalid due to lack of industrial application

Saved in:
Bibliographic Details
Published inJournal of generic medicines Vol. 6; no. 1; p. 68
Main Authors Burdon, Michael, Armstrong, James, Katzka, Catherine, MacIntyre, Jade
Format Journal Article
LanguageEnglish
Published Sage Publications Ltd. (UK) 01.11.2008
Subjects
Health aspects
Intellectual property
Patent infringement
Pharmaceutical industry
Stent (Surgery)
Canada
United Kingdom
Online AccessGet full text

Cover

More Information
ISSN:1741-1343
1741-7090